Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126253131 | 12625313 | 1 | I | 20150317 | 20150923 | 20160805 | 20160805 | EXP | FR-PFIZER INC-3021123 | PFIZER | 60.00 | YR | F | Y | 0.00000 | 20160805 | CN | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126253131 | 12625313 | 1 | PS | Paclitaxel Hospira | PACLITAXEL | 1 | Intravenous (not otherwise specified) | UNK UNK, CYCLIC (6 MG/ML) | 76131 | SOLUTION FOR INJECTION | |||||||||
| 126253131 | 12625313 | 2 | SS | CARBOPLATIN KABI | CARBOPLATIN | 1 | Intravenous (not otherwise specified) | UNK UNK, CYCLIC (10 MG/ML) | 0 | CONCENTRATE FOR SOLUTION FOR INFUSION | |||||||||
| 126253131 | 12625313 | 3 | SS | CARBOPLATIN KABI | CARBOPLATIN | 1 | Intravenous (not otherwise specified) | UNK UNK, CYCLIC (10 MG/ML) | 0 | CONCENTRATE FOR SOLUTION FOR INFUSION | |||||||||
| 126253131 | 12625313 | 4 | SS | AVASTIN | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | UNK UNK, CYCLIC (25 MG/ML) | N | 0 | CONCENTRATE FOR SOLUTION FOR INFUSION | ||||||||
| 126253131 | 12625313 | 5 | SS | AVASTIN | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | UNK, MONTHLY | N | 0 | CONCENTRATE FOR SOLUTION FOR INFUSION | /month | |||||||
| 126253131 | 12625313 | 6 | SS | ALIMTA | PEMETREXED DISODIUM | 1 | Intravenous (not otherwise specified) | UNK UNK, CYCLIC (500 MG) | 0 | POWDER FOR SOLUTION FOR INFUSION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126253131 | 12625313 | 1 | Lung adenocarcinoma |
| 126253131 | 12625313 | 2 | Lung adenocarcinoma |
| 126253131 | 12625313 | 4 | Lung adenocarcinoma |
| 126253131 | 12625313 | 6 | Lung adenocarcinoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126253131 | 12625313 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126253131 | 12625313 | Asthenia | |
| 126253131 | 12625313 | Bundle branch block left | |
| 126253131 | 12625313 | Cardiomyopathy | |
| 126253131 | 12625313 | Dyspnoea | |
| 126253131 | 12625313 | Myalgia | |
| 126253131 | 12625313 | Tachycardia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126253131 | 12625313 | 1 | 20131008 | 20140212 | 0 | |
| 126253131 | 12625313 | 2 | 20130123 | 20130327 | 0 | |
| 126253131 | 12625313 | 3 | 20131008 | 20140212 | 0 | |
| 126253131 | 12625313 | 4 | 20131008 | 20140212 | 0 | |
| 126253131 | 12625313 | 5 | 20140326 | 20150408 | 0 | |
| 126253131 | 12625313 | 6 | 20130123 | 20130327 | 0 |